Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery

To see complete record on, please visit this link

Id: NCT02113150

Organisation Name: Turkiye Yuksek Ihtisas Education and Research Hospital

Overal Status: Completed

Start Date: May 2013

Last Update: April 14, 2014

Lead Sponsor: Turkiye Yuksek Ihtisas Education and Research Hospital

Brief Summary: In this prospective, randomized, clinical trial, we have investigated the effects of ketamine-based and remifentanil-based anesthetic protocol on perioperative serum cystatin-c levels, and creatinine and/or cystatin-c based eGFR equations in terms of acute kidney injury in CABG surgery.This study was approved by the Ethics Committee of Hospital and all patients were informed and gave written consent. Patients scheduled for elective CABG with cardiopulmonary bypass. Patients were randomly allocated to anesthesia with remifentanil-propofol-midazolam (RPM) group or ketamine-propofol-midazolam (KPM) group. Blood samples were obtained before induction of anesthesia (baseline), at the end of the operation, and postoperative days 1, 2, and 4.

  • Coronary Artery Disease

Total execution time in seconds: 0.20017910003662